Granite Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History

Granite Investment Partners’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-38,582	Closed	-$663K	–	357
2018 Q4	$663K	Buy	38,582 +13,467	+54%	+$230K	0.05%	217
2018 Q3	$370K	Hold	25,115	–	–	0.02%	268
2018 Q2	$599K	Hold	25,115	–	–	0.04%	216
2018 Q1	$642K	Sell	25,115 -44,805	-64%	-$1.07M	0.04%	196
2017 Q4	$1.29M	Buy	69,920 +17,784	+34%	+$255K	0.08%	181
2017 Q3	$547K	Sell	52,136 -27,263	-34%	-$301K	0.03%	263
2017 Q2	$994K	Buy	+79,399	New	+$785K	0.07%	233

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Granite Investment Partners's COLL Position: Q1 2019 in Review

Granite Investment Partners sold out of Collegium Pharmaceutical (COLL) in Q1 2019, closing a stake of 38,582 shares — an estimated $663K sold.

Granite Investment Partners first reported a position in COLL in Q2 2017 and held it in 7 quarters. The position peaked at $1.29M in Q4 2017. 145 funds tracked by Wall St. Rank hold COLL as of Q1 2019.

Granite Investment Partners reported no remaining Collegium Pharmaceutical position as of Q1 2019 after selling out during the quarter.
Granite Investment Partners sold 38,582 Collegium Pharmaceutical shares in Q1 2019, an estimated $663K.
Granite Investment Partners first reported a position in Collegium Pharmaceutical in Q2 2017 and held it in 7 quarters.
Granite Investment Partners's Collegium Pharmaceutical position peaked at $1.29M in Q4 2017.
145 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2019.

Based on Granite Investment Partners's 13F filing for Q1 2019, filed 13 May 2019.